A carregar...

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

There is much interest in the potential use of Cox-2 selective inhibitors in combination with other cancer therapeutics. Malignancies of hematopoietic and non-hematopoietic origin often have increased expression of cyclooxygenase-2 (Cox-2), a key modulator of inflammation. For example, hematological...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bernard, M. P., Bancos, S., Sime, P. J., Phipps, R. P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745246/
https://ncbi.nlm.nih.gov/pubmed/18691115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!